Identification of Lynch Syndrome
- PMID: 34798986
- DOI: 10.1016/j.giec.2021.09.002
Identification of Lynch Syndrome
Abstract
Lynch syndrome (LS) is an autosomal dominant hereditary cancer syndrome caused by pathogenic germline variants (PGV) in any of the 4 DNA mismatch repair (MMR) genes, MLH1, MSH2, MSH6, and PMS2, or deletions in EPCAM. LS leads to an increased risk of intestinal and extraintestinal cancers, of which colorectal and endometrial cancers are the most common. Individuals at risk for LS can be identified by using clinical criteria, prediction models, and universal tumor testing. Understanding each of these tools, including limitations and mimics of LS, is essential to the early identification of at-risk individuals.
Keywords: Hereditary colorectal cancer syndrome; Hereditary nonpolyposis colorectal cancer; Lynch syndrome; Mismatch repair.
Published by Elsevier Inc.
Conflict of interest statement
Disclosure Dr. Maratt receives support from Grant Number UL1TR002529 from the National Institutes of Health (NIH), National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The views expressed in this manuscript do not reflect views of the NIH.
Similar articles
-
Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.Hum Pathol. 2017 Dec;70:121-128. doi: 10.1016/j.humpath.2017.10.022. Epub 2017 Oct 28. Hum Pathol. 2017. PMID: 29107668
-
Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.Pathology. 2017 Aug;49(5):457-464. doi: 10.1016/j.pathol.2017.05.004. Epub 2017 Jun 30. Pathology. 2017. PMID: 28669579
-
Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.Diagn Pathol. 2024 Jan 31;19(1):25. doi: 10.1186/s13000-024-01447-8. Diagn Pathol. 2024. PMID: 38297350 Free PMC article.
-
Mismatch repair deficiency testing in clinical practice.Expert Rev Mol Diagn. 2016;16(5):591-604. doi: 10.1586/14737159.2016.1156533. Epub 2016 Mar 10. Expert Rev Mol Diagn. 2016. PMID: 26895074 Review.
-
Update on Lynch syndrome genomics.Fam Cancer. 2016 Jul;15(3):385-93. doi: 10.1007/s10689-016-9882-8. Fam Cancer. 2016. PMID: 26873718 Free PMC article. Review.
Cited by
-
Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes.Curr Issues Mol Biol. 2024 Jun 26;46(7):6440-6471. doi: 10.3390/cimb46070385. Curr Issues Mol Biol. 2024. PMID: 39057027 Free PMC article. Review.
-
Current status of inherited pancreatic cancer.Hered Cancer Clin Pract. 2022 Jun 27;20(1):26. doi: 10.1186/s13053-022-00224-2. Hered Cancer Clin Pract. 2022. PMID: 35761384 Free PMC article. Review.
-
Current prospects of hereditary adrenal tumors: towards better clinical management.Hered Cancer Clin Pract. 2024 Mar 26;22(1):4. doi: 10.1186/s13053-024-00276-6. Hered Cancer Clin Pract. 2024. PMID: 38532453 Free PMC article. Review.
-
Hereditary Colorectal Cancer: State of the Art in Lynch Syndrome.Cancers (Basel). 2022 Dec 23;15(1):75. doi: 10.3390/cancers15010075. Cancers (Basel). 2022. PMID: 36612072 Free PMC article. Review.
-
The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial.Trials. 2023 Feb 10;24(1):105. doi: 10.1186/s13063-023-07125-2. Trials. 2023. PMID: 36765432 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous